Clariane: Tap issue in the amount of €100M of its notes due June 27th, 2030, bringing its total amount to €500m

Press release

August 1^st, 2025

Clariane has successfully completed a tap issue in the amount of 100 million euros of its notes due June 27, 2030, bringing its total amount to 500 million euros

Paris, 1^st August 2025 - Clariane (CLARI.PA - ISIN FR0010386334), announces today that it has successfully completed a tap issue of its notes due June 27, 2030, for an amount of 100 million euros, with an annual coupon of 7.875% (the "Notes"), bringing the total amount of the Notes and the existing notes to 500 million euros. The Notes will be fully assimilated and form a single series with the existing notes issued on 27 June 2025.

The net proceeds from this tap issue will be used to refinance its existing debt (including the redemption of its OCEANE).

An application will be made for these Notes to be admitted to trading on the Global Exchange Market of Euronext Dublin.

Settlement and admission to trading are expected to take place on 8 August 2025.

This tap issue was led by Morgan Stanley as Sole Global Coordinator and Active Bookrunner.

Disclaimer

This press release and the information contained herein do not constitute an offer to sell or subscribe, nor a solicitation of an order to purchase or subscribe the notes in any country, in particular in the United States. This press release and the information contained herein also do not constitute an offer to purchase nor a solicitation to sell the notes, nor an invitation to participate to the offer to purchase. The distribution of this press release may be restricted in some countries and be subject to specific regulations and persons in possession of this press release should inform themselves about and comply with any applicable restrictions.

This document contains forward-looking statements that involve risks and uncertainties, including those included or incorporated by reference, concerning the Group's future growth and profitability that could cause actual results to differ materially from those indicated in the forward-looking statements. These risks and uncertainties relate to factors that the Company cannot control or estimate precisely, such as future market conditions. The forward-looking statements made in this document constitute expectations for the future and should be regarded as such. Actual events or results may differ from those described in this document due to a number of risks and uncertainties described in Chapter 2 of the 2024 Universal Registration Document filed with the AMF on 1 April 2025 under registration number D.25-0209, available on the Company's website (www.clariane.com) and that of the AMF (www.amf-france.org). All forward-looking statements included in this document are valid only as of the date of this press release. Clariane S.E. undertakes no obligation and assumes no responsibility to update the information contained herein beyond the requirements of applicable regulations.

Readers are cautioned not to place undue reliance on these forward-looking statements. Neither Clariane nor any of its directors, officers, employees, agents, affiliates or advisors accepts any responsibility for the reasonableness of any assumptions or opinions expressed or for the likelihood of any projections, prospects or performance being achieved. Any liability for such information is expressly excluded. Nothing in this document is, or should be construed as a promise or representation regarding the future. Furthermore, nothing contained in this document is intended to be or should be construed as a forecast of results. Clariane's past performance should not be taken as a guide to future performance.

The main Alternative Performance Indicators (APIs), such as EBITDA, EBIT, net debt and financial leverage, are defined in the Universal Registration Document available on the Company's website at www.clariane.com.

About Clariane

Clariane is the leading European community of care in times of vulnerability. It has operations in six countries: Belgium, France, Germany, Italy, the Netherlands and Spain.
Relying on their diverse expertise, each year, the Group's 63,000 professionals provide services to nearly 900,000 patients and residents in three main areas of activity: care homes (Korian, Seniors Residencias, etc.), healthcare facilities and services (Inicea, Ita, Grupo 5, etc.), and alternative living solutions (Ages & Vie, etc.).
In June 2023, Clariane became a purpose-driven company and added to its bylaws a new corporate purpose, common to all its activities: "taking care of each person's humanity in times of vulnerability".

Clariane has been listed on Euronext Paris, Section B since November 2006. The Group joined the SBF 120 index and the CAC® SBT 1.5° index on 23 September 2024.

Euronext ticker: CLARI.PA - ISIN: FR0010386334.

Stéphane BisseuilBenoît Lesieur
Head of Investor Relations Deputy Head of Investor Relations - ESG
[phone] [phone]
[e-mail] [e-mail]

Julie MaryFlorian Bachelet

Press officer Press officer

[phone] [phone]
[e-mail] [e-mail]